Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)

NCT02247934 is registered in ClinicalTrials.gov with Gilead Sciences as lead sponsor.

NCT NCT02247934
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02247934 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development of a Patient-Reported Outcome Measure to Assess Symptoms in Patients With Primary Sclerosing Cholangitis (PSC)
Lead sponsor
Gilead Sciences
Phase
Observational
Overall status
Completed
Start date
October 31, 2014
Completion date
October 31, 2015
Enrollment
26 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

primary sclerosing cholangitis